ICL矫治中低度近视的优势与挑战  

ICL implantation for moderate and low myopia

作　　者：李广岳 万修华[1] Li Guangyue;Wan Xiuhua(Beijing Tongren Eye Center,Beijing Tongren Hospital,Capital Medical University,Beijing Key Laboratory of Ophthalmology and Visual Sciences,Beijing 100730,China)

机构地区：[1]首都医科大学附属北京同仁医院、北京同仁眼科中心,眼科学与视觉科学北京市重点实验室,北京100730

出　　处：《国际眼科纵览》2024年第6期438-442,共5页International Review of Ophthalmology

基　　金：国家自然科学基金(82171037,82471055);北京市科技新星交叉联合课题(20240484565)。

摘　　要：目前传统的角膜屈光手术如准分子激光角膜切削术仍是矫治近视的主要方法。但由于角膜屈光手术需切削部分角膜组织,其应用受到角膜厚度和角膜曲率的限制。有晶状体眼人工晶状体(implantable collamer lens,ICL)植入术不削减角膜厚度,能避免术后角膜前后膨隆等多种并发症。以往由于眼内植入材料的限制、形态设计的单一以及治疗观念的局限,ICL植入术多被用于矫治高度近视眼。近年来,随着新型眼内植入材料的研发和治疗观念的拓展,越来越多的研究证据显示:ICL植入术在中低度近视眼的矫治上同样具有显著效果,疗效可与传统近视眼激光手术相媲美。对于无法或不愿意接受角膜屈光手术的近视患者,ICL植入成为其矫治选择,可有效地矫正近视并获得优质的视觉体验。Currently,traditional corneal refractive surgery,such as excimer laser surgery,is the main treatment for myopia.However,corneal refractive surgery requires the removal of a portion of the cornea,which limits its application due to the corneal thickness and curvature constraints.In contrast,implantable collamer lens(ICL)does not require cornea resection,avoiding postoperative corneal ectasia and other complications.In the past,due to limitations in intraocular lens materials,design diversity,and therapeutic concepts,ICL implantation was mainly used for the treatment of high myopia.In recent years,with the development of novel intraocular lens materials and expanded therapeutic concepts,there has been increasing evidence that ICL implantation has a significant effect in the treatment of low to moderate myopia,comparable to conventional laser refractive surgery.Therefore,for individuals who cannot or do not wish to undergo corneal refractive surgery,ICL implantation has become a treatment option that can effectively correct myopia and provide visual experience.

关 键 词：近视 屈光手术 有晶状体眼人工晶状体 

分 类 号：R779.6[医药卫生—眼科]